Our results thus demonstrate that ZEB1 is a major driver of phenotype switching‐mediated resistance to MAPKi and highlight that it is not the EMT phenotype or invasive status itself but the specific functions of EMT‐TFs that cause resistance in melanoma cells. This evidence concerns the gene ZEB1 and melanoma.